Australia Frees $5.5 Million For 41 Fast-Tracked H1N1 Research Projects
This article was originally published in PharmAsia News
Executive Summary
Australia's Health Ministry says it will offer U.S.$5.5 million to cover 41 new medical research projects delving into the H1N1 flu outbreak. The health minister said the new effort is being made to help the government determine a response to the outbreak that has grown to 6,378 confirmed cases in Australia. The 41 projects already had been given fast-track approval for funding, some of them to find and develop antivirals, some into specific areas of the disease. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.